Specialty Pharmacy

Interaction between focal adhesion kinase and myosin increases cancer cell proliferation and metastasis.

FDA requires additional clinical data to determine the most appropriate doses of Olumiant (baricitinib) for the treatment of rheumatoid arthritis (RA).

Top five articles of the week from Specialty Pharmacy Times.

The activation of the STAT5 protein linked to acute lymphoblastic leukemia.

Data and collaboration are crucial to implementing value-based care.

Patients with certain characteristics observed to experience hyper-progression of cancer growth on immunotherapy.

Inflammatory bowel disease may increase risk of nonalcoholic fatty liver disease.

Novel therapeutic approach may help cure patients with HIV in the future.

Women with insurance coverage for in vitro fertilization are more likely to give birth.

Scientists uncover how anti-CRISPR proteins are used to the surveillance complex of gene-editing technology.

Study finds miR-219 restarts myelin production in nerves of mice with multiple sclerosis.

Patient outcomes dependent on collaboration between specialty pharmacists and physicians.

The second of 4-part interview with an infectious disease expert examines weighing the short-term high cost of treating HCV with curative drugs versus the long-term costs of treating the disease.

Mark Wainberg, PhD was an influential researcher from the start of the AIDS epidemic.

College-educated Hispanic patients had a lower risk of poor mental quality of life, study shows.

Dexamethasone or rapamycin may raise blood glucose to dangerous levels, leading to healthy cell death.

Study suggests funding cuts to the National Institutes of Health could delay new treatments for neurological diseases that reduce spending.

Mark A. Vineis, vice president of Specialty Pharmacy at Cardinal Health, discusses how specialty pharmacies can help achieve the goals of accountable care organizations.

Individuals susceptible to hepatitis infection may also be susceptible to Parkinson’s disease.

Top news of the day from across the health care landscape.

Part 1 of a 4-part interview with an infectious disease expert explores treatment advances in HIV since the AIDS epidemic in the 1980s.

A novel polymer capsule may be able to deliver cancer drugs to a tumor site.

New technique determines whether cells have been exposed to a cancer-causing toxin.

Employing proteogenomics helps identifies therapeutic targets in breast cancer.

Nearly 70% of patients with HIV take dietary supplements with their antiretroviral therapy.

Program simulates the physiology of the human body to provide a response model to diseases, medications, and chemicals.

Women given vitamin D3 and calcium supplements had a 30% lower risk of cancer.

Top news of the day from across the health care landscape.